Evidence map›Paper›PMID 32443503›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Nanoparticulate Gels for Cutaneous Administration of Caffeic Acid.

Maddalena Sguizzato, Paolo Mariani, Francesca Ferrara, Markus Drechsler, Supandeep Singh Hallan, Nicolas Huang, Fanny Simelière, Nikul Khunti, Rita Cortesi, Nicola Marchetti and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Development of Spray DriedAntioxidants (Basel, Switzerland) · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Ultraviolet Light Protection: Is It Really Enough?Antioxidants (Basel, Switzerland) · 2022
    Review
  15. Review
  16. International journal of molecular sciences · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Lipid-Based Nanosystems as a Tool to Overcome Skin Barrier.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 5 countries.

Maddalena SguizzatoDepartment of Chemical and Pharmaceutical Sciences, University of Ferrara, I-44121 Ferrara, Italy.ORCID 0000-0002-2100-2043
Paolo MarianiDepartment of Life and Environmental Sciences, Polytechnic University of Marche, I-60131 Ancona, Italy.ORCID 0000-0003-4293-1009
Francesca FerraraDepartment of Biomedical and Specialist Surgical Sciences, University of Ferrara, I-44121 Ferrara, Italy.ORCID 0000-0002-9096-0560
Markus DrechslerBavarian Polymer Institute (BPI) Keylab "Electron and Optical Microscopy", University of Bayreuth, D-95440 Bayreuth, Germany.ORCID 0000-0001-7192-7821
Supandeep Singh HallanDepartment of Chemical and Pharmaceutical Sciences, University of Ferrara, I-44121 Ferrara, Italy.ORCID 0000-0002-2882-0719
Nicolas HuangInstitut Galien Paris Sud, CNRS, Université Paris-Saclay, 92296 Châtenay-Malabry, France.ORCID 0000-0003-2750-3778
Fanny SimelièreInstitut Galien Paris Sud, CNRS, Université Paris-Saclay, 92296 Châtenay-Malabry, France.
Nikul KhuntiDiamond Light Source Ltd., Diamond House, Harwell Science and Innovation Campus, Didcot, Oxfordshire OX11 0QG, UK.
Rita CortesiDepartment of Chemical and Pharmaceutical Sciences, University of Ferrara, I-44121 Ferrara, Italy.ORCID 0000-0002-1060-2676
Nicola MarchettiDepartment of Chemical and Pharmaceutical Sciences, University of Ferrara, I-44121 Ferrara, Italy.
Giuseppe ValacchiDepartment of Biomedical and Specialist Surgical Sciences, University of Ferrara, I-44121 Ferrara, Italy.
Elisabetta EspositoDepartment of Chemical and Pharmaceutical Sciences, University of Ferrara, I-44121 Ferrara, Italy.ORCID 0000-0002-8416-3629
University of Ferrara · ITCentre National de la Recherche Scientifique · FRBavarian Polymer Institute · DEDiamond Light Source · GBMarche Polytechnic University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Caffeic acid is a natural antioxidant, largely distributed in plant tissues and food sources, possessing anti-inflammatory, antimicrobial, and anticarcinogenic properties. The object of this investigation was the development of a formulation for caffeic acid cutaneous administration. To this aim, caffeic acid has been loaded in solid lipid nanoparticles by hot homogenization and ultrasonication, obtaining aqueous dispersions with high drug encapsulation efficiency and 200 nm mean dimension, as assessed by photon correlation spectroscopy. With the aim to improve the consistence of the aqueous nanodispersions, different types of polymers have been considered. Particularly, poloxamer 407 and hyaluronic acid gels containing caffeic acid have been produced and characterized by X-ray and rheological analyses. A Franz cell study enabled to select poloxamer 407, being able to better control caffeic acid diffusion. Thus, a nanoparticulate gel has been produced by addition of poloxamer 407 to nanoparticle dispersions. Notably, caffeic acid diffusion from nanoparticulate gel was eight-fold slower with respect to the aqueous solution. In addition, the spreadability of nanoparticulate gel was suitable for cutaneous administration. Finally, the antioxidant effect of caffeic acid loaded in nanoparticulate gel has been demonstrated by ex-vivo evaluation on human skin explants exposed to cigarette smoke, suggesting a protective role exerted by the nanoparticles.

Indexed as

caffeic acidcigarette smokepoloxamersmall angle X-ray scatteringsolid lipid nanoparticles

Identifiers

PMID32443503
PMCPMC7279527
OpenAlexW3024232105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.